is glp 1 tirzepatide Compounded GLP-1 - Semaglutide & Systemic effects of tirzepatide dually

What sets Replenza apart from many supplement startups is its distribution strategy

Here is how GLP-1 options compare, according to clinical trials: Daily oral semaglutide (Wegovy): Average weight loss of 13.6 percent of body weight after about 15 months of treatment, compared with 2.2 percent in a placebo group Average weight loss of 11.2 percent of body weight after 72 weeks of treatment, compared with 2.1 percent in the placebo group

doi: 10.1073/pnas.94.7.3223

Kovacic P

84 The reasons for this are not clear, but it has been suggested that chronic constipation may be a symptom of diabetes complications, and longitudinal studies are needed to evaluate the temporal relationship between the onset of chronic constipation and other diabetes complications

All samples were sequenced on Illumina HiSeq X instruments to obtain WGS with a target average depth of coverage of 30